Medionn Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 19-07-2024
- Paid Up Capital ₹ 9.90 Cr
as on 19-07-2024
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.37 Cr
as on 19-07-2024
- Revenue 7.26%
(FY 2023)
- Profit -25.98%
(FY 2023)
- Ebitda -18.46%
(FY 2023)
- Net Worth 72.50%
(FY 2023)
- Total Assets 24.04%
(FY 2023)
About Medionn Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.90 Cr.
The company currently has active open charges totaling ₹11.37 Cr.
Govind Agarwal, Biswanath Roy, Anukul Agarwal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999WB2016PLC218034
- Company No.
218034
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Oct 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Howrah, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Medionn Diagnostics?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naman Garg  | Director | 24-May-2018 | Current |
| Govind Agarwal | Director | 19-Oct-2016 | Current |
| Biswanath Roy | Director | 05-Mar-2022 | Current |
| Anukul Agarwal | Director | 19-Oct-2016 | Current |
| Vishal Agarwal | Director | 12-Jun-2024 | Current |
Financial Performance of Medionn Diagnostics.
Medionn Diagnostics Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.26% increase. The company also saw a substantial fall in profitability, with a 25.98% decrease in profit. The company's net worth Soared by an impressive increase of 72.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medionn Diagnostics?
In 2023, Medionn Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Midnapore Diagnostics Private LimitedActive 22 years 3 monthsGovind Agarwal and Biswanath Roy are mutual person
Firstlab Diagnostics LlpActive 4 years 2 monthsGovind Agarwal, Anukul Agarwal and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 Jan 2024 | ₹1.30 Cr | Open |
Others Creation Date: 25 Jan 2023 | ₹7.50 Cr | Open |
Hdfc Bank Limited Creation Date: 30 Dec 2020 | ₹2.57 Cr | Open |
How Many Employees Work at Medionn Diagnostics?
Medionn Diagnostics has a workforce of 88 employees as of Jul 16, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medionn Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medionn Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
